Log In
Sign Up
Forgotten Password
Upgrade to a paid membership and never see an advert again!
Why do we display adverts? The advertisements supplied by our carefully selected sponsors enable us to host and support the company data we share with our free members.
Watch this company for free updates
Simply enter your email address below and we will send you an email when the company files any documents or there is a change to their credit report.
We require your email address in order to send you alerts by email. You can unsubscribe at any time.
Thank you, you are now watching this company.
You will receive email updates when this company's information changes.
You can choose which alerts you receive and can unsubscribe at any time.
Unlock HEART BIOTECH LIPO LIMITED's Credit Report?
Buy This Report
Upgrade to Lite
Your plan will start immediately and the time remaining on your existing plan will be refunded
Yes, upgrade to Lite
17,
North Drive,
Winchester,
Hampshire,
SO22 6QA
HEART BIOTECH LIPO LIMITED
Private limited with Share Capital
Company is dissolved
22 December 2014
86900 Other human health activities - Other human health activities
Available to 08 May 2025. Next accounts due by 30 Jun 2026
Don't write it off. As exclusively featured on Can't Pay? We'll Take It Away!, DCBL provides a nationwide service recovering over £85 million annually.
Our unique "One Solution" works seamlessly with DCB Legal, managing debt recovery from the first letter through to High Court enforcement.
We act fast to protect your cash flow and recover what you're owed. Recover your debt with the UK's experts.
For a full in-depth analysis on each of these directors, click any of the links below
| Name | Role | Date Of Birth | Appointed |
|---|---|---|---|
| Mr Francis William White | Director | ||
| Mr Mark Christopher Radford | Director | ||
| Professor Sir Magdi Habib Yacoub | Director | ||
| Dr Magdy Adib Ishak-Hanna | Director | ||
| Mr Samer Said Khoury | Director | ||
| Mr Ian Ashley Richardson | Director |
| Accounts | |||||
|---|---|---|---|---|---|
| Cash | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 |
| Net Worth | £1.00 | £1.00 | £1.00 | £1.00 | £1.00 |
| Total Current Liabilities | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 |
| Total Current Assets | £1.00 | £1.00 | £0.00 | £0.00 | £1.00 |
Detailed answers about HEART BIOTECH LIPO LIMITED, including incorporation, status, business activity, and accounts information.
HEART BIOTECH LIPO LIMITED was officially incorporated on 22 December 2014 and is registered under company number 09364980. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
Private limited with Share Capital. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. For example, a private limited company (Ltd) limits the personal liability of its shareholders.
HEART BIOTECH LIPO LIMITED's current status is NonActive. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
HEART BIOTECH LIPO LIMITED operates in the following sector: 86900 Other human health activities - Other human health activities . This provides insight into the company’s primary business activities and industry focus. Knowing the SIC code and description is useful for market research, assessing competitors, and understanding potential business risks.
The registered office address of HEART BIOTECH LIPO LIMITED is 17, North Drive, Winchester, Hampshire, SO22 6QA. This is the official address filed with Companies House for legal and statutory correspondence.
Based on the latest accounts up to 08 May 2025, HEART BIOTECH LIPO LIMITED has filed financial statements showing its assets, liabilities, and overall trading performance. The next accounts are due by 30 Jun 2026. Reviewing these accounts helps assess the company’s financial stability, creditworthiness, and risk profile, which is crucial for investors, suppliers, and potential business partners.